154 related articles for article (PubMed ID: 7658724)
21. Functional expression of MDR-1 in acute myeloid leukemia: correlation with the clinical-biological, immunophenotypical, and prognostic disease characteristics.
Martínez A; San Miguel JF; Valverde B; Bárez A; Moro MJ; García-Marcos MA; Pérez-Simón JA; Vidriales B; Orfao A
Ann Hematol; 1997 Sep; 75(3):81-6. PubMed ID: 9368475
[TBL] [Abstract][Full Text] [Related]
22. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF;
Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321
[TBL] [Abstract][Full Text] [Related]
23. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
Filipits M; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
Clin Cancer Res; 1997 Aug; 3(8):1419-25. PubMed ID: 9815827
[TBL] [Abstract][Full Text] [Related]
24. Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells.
Suárez L; Vidriales MB; Moreno MJ; López A; García-Laraña J; Pérez-López C; Tormo M; Lavilla E; López-Berges MC; de Santiago M; San Miguel JF; Orfao A;
Haematologica; 2005 Jan; 90(1):54-9. PubMed ID: 15642669
[TBL] [Abstract][Full Text] [Related]
25. Rhodamine 123 efflux in human subpopulations of hematopoietic stem cells: comparison between bone marrow, umbilical cord blood and mobilized peripheral blood CD34+ cells.
Wagner-Souza K; Diamond HR; Ornellas MH; Gomes BE; Almeida-Oliveira A; Abdelhay E; Bouzas LF; Rumjanek VM
Int J Mol Med; 2008 Aug; 22(2):237-42. PubMed ID: 18636179
[TBL] [Abstract][Full Text] [Related]
26. [Flow cytometric analysis of P-glycoprotein function by rhodamine 123 dye-efflux assay in human leukemia cells].
Kawabata M; Kobayashi H; Mori S; Sekiguchi S; Takemura Y
Rinsho Byori; 1997 Sep; 45(9):891-8. PubMed ID: 9311264
[TBL] [Abstract][Full Text] [Related]
27. Multidrug resistance expression and proliferative studies in poor risk acute myeloid leukemia treated with the FLAG (G-CSF plus fludarabine and Ara-C) regimen.
Tafuri A; De Felice L; Petrucci MT; Mascolo MG; Ricciardi MR; Ciliberti C; Martelli MP; Petti MC
Cytokines Mol Ther; 1995 Dec; 1(4):301-7. PubMed ID: 9384683
[TBL] [Abstract][Full Text] [Related]
28. Expression of P-glycoprotein in de novo acute myelogenous leukemia at initial diagnosis: results of molecular and functional assays, and correlation with treatment outcome.
Ino T; Miyazaki H; Isogai M; Nomura T; Tsuzuki M; Tsuruo T; Ezaki K; Hirano M
Leukemia; 1994 Sep; 8(9):1492-7. PubMed ID: 7916390
[TBL] [Abstract][Full Text] [Related]
29. The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype.
Damiani D; Tiribelli M; Raspadori D; Michelutti A; Gozzetti A; Calistri E; Candoni A; Chiarvesio A; Lenoci M; Russo D; Fanin R
Hematol Oncol; 2007 Mar; 25(1):38-43. PubMed ID: 17200981
[TBL] [Abstract][Full Text] [Related]
30. Contrasting features of MDR phenotype in leukemias by using two fluorochromes: implications for clinical practice.
Vasconcelos FC; Cavalcanti GB; Silva KL; de Meis E; Kwee JK; Rumjanek VM; Maia RC
Leuk Res; 2007 Apr; 31(4):445-54. PubMed ID: 16979236
[TBL] [Abstract][Full Text] [Related]
31. DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
Minderman H; Vanhoefer U; Toth K; Yin MB; Minderman MD; Wrzosek C; Slovak ML; Rustum YM
Cytometry; 1996 Sep; 25(1):14-20. PubMed ID: 8875050
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins.
Candoni A; Michelutti A; Simeone E; Damiani D; Baccarani M; Fanin R
Eur J Haematol; 2006 Oct; 77(4):293-9. PubMed ID: 16856922
[TBL] [Abstract][Full Text] [Related]
33. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
van der Kolk DM; de Vries EG; van Putten WJ; Verdonck LF; Ossenkoppele GJ; Verhoef GE; Vellenga E
Clin Cancer Res; 2000 Aug; 6(8):3205-14. PubMed ID: 10955805
[TBL] [Abstract][Full Text] [Related]
34. Discordant P-glycoprotein antigen expression and transport function in acute myeloid leukemia.
Xie XY; Robb D; Chow S; Hedley DW
Leukemia; 1995 Nov; 9(11):1882-7. PubMed ID: 7475279
[TBL] [Abstract][Full Text] [Related]
35. P-glycoprotein expression in patients with acute leukemia-clinical relevance.
Nüssler V; Pelka-Fleischer R; Zwierzina H; Nerl C; Beckert B; Gieseler F; Diem H; Ledderose G; Gullis E; Sauer H; Wilmanns W
Leukemia; 1996 Jul; 10 Suppl 3():S23-S31. PubMed ID: 8656697
[TBL] [Abstract][Full Text] [Related]
36. Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity.
Broxterman HJ; Sonneveld P; Feller N; Ossenkoppele GJ; Währer DC; Eekman CA; Schoester M; Lankelma J; Pinedo HM; Löwenberg B; Schuurhuis GJ
Blood; 1996 Jun; 87(11):4809-16. PubMed ID: 8639853
[TBL] [Abstract][Full Text] [Related]
37. P-glycoprotein expression in de novo acute myeloid leukemia.
Del Poeta G; Venditti A; Aronica G; Stasi R; Cox MC; Buccisano F; Bruno A; Tamburini A; Suppo G; Simone MD; Epiceno AM; Del Moro B; Masi M; Papa G; Amadori S
Leuk Lymphoma; 1997 Oct; 27(3-4):257-74. PubMed ID: 9402325
[TBL] [Abstract][Full Text] [Related]
38. [The causes of treatment ineffectiveness in acute myelogenous leukemia--the role of blast resistance to cytotoxic drugs].
Machaczka M; Rucińska M; Jabłoński M; Skotnicki AB
Przegl Lek; 1998; 55(7-8):407-13. PubMed ID: 10021886
[TBL] [Abstract][Full Text] [Related]
39. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.
Lee EJ; Yang J; Leavitt RD; Testa JR; Civin CI; Forrest A; Schiffer CA
Leukemia; 1992 Nov; 6(11):1203-9. PubMed ID: 1279324
[TBL] [Abstract][Full Text] [Related]
40. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.
Ludescher C; Thaler J; Drach D; Drach J; Spitaler M; Gattringer C; Huber H; Hofmann J
Br J Haematol; 1992 Sep; 82(1):161-8. PubMed ID: 1358171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
